Login / Signup

High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study.

Yuan YangQinglin HuChen YangMiao ChenBing Han
Published in: Hematology (Amsterdam, Netherlands) (2023)
Adding a higher dose of rhTPO can further accelerate platelet recovery and platelet transfusion independence in patients with newly diagnosed NSAA.
Keyphrases
  • newly diagnosed
  • recombinant human
  • chronic kidney disease
  • cardiac surgery
  • early onset
  • allogeneic hematopoietic stem cell transplantation
  • sickle cell disease
  • acute myeloid leukemia
  • acute lymphoblastic leukemia